AQST - Aquestive Therapeutics EPS beats by $0.06 beats on revenue November, 02 2021 05:17 PM Aquestive Therapeutics Inc. Aquestive Therapeutics (NASDAQ:AQST): Q3 GAAP EPS of -$0.37 beats by $0.06. Revenue of $13.28M (+60.0% Y/Y) beats by $2.27M. Press Release For further details see: Aquestive Therapeutics EPS beats by $0.06, beats on revenue